Should high molecular weight forms of apolipoprotein A-I be analyzed in urine of relapsing FSGS patients?
Pediatr Nephrol
.
2019 Nov;34(11):2423-2424.
doi: 10.1007/s00467-019-04309-4.
Epub 2019 Jul 24.
Authors
Conxita Jacobs-Cachá
1
2
,
Joan López-Hellín
3
4
Affiliations
1
Nephrology Research Group, Hospital Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. conxita.jacobs@vhir.org.
2
Nephrology Department, Hospital Vall d'Hebrón, Barcelona, Spain. conxita.jacobs@vhir.org.
3
Biochemistry Research Group, Hospital Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
4
Biochemistry Department, Hospital Vall d'Hebrón, Barcelona, Spain.
PMID:
31342149
DOI:
10.1007/s00467-019-04309-4
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Apolipoprotein A-I
Child
Glomerulosclerosis, Focal Segmental*
Humans
Kidney Diseases*
Molecular Weight
Proteinuria
Substances
Apolipoprotein A-I